Ischemic acute tubular necrosis models and drug discovery: a focus on cellular inflammation
- 30 April 2006
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 11 (7-8), 364-370
- https://doi.org/10.1016/j.drudis.2006.02.010
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Amelioration of Ischemic Acute Renal Injury by Neutrophil Gelatinase-Associated LipocalinJournal of the American Society of Nephrology, 2004
- Inflammatory cells in ischemic acute renal failureKidney International, 2004
- Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injuryKidney International, 2003
- Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analogKidney International, 2003
- The role of adhesion molecules and T cells in ischemic renal injuryCurrent Opinion in Nephrology and Hypertension, 2003
- Protective Effect of HMG-CoA Reductase Inhibitor on Experimental Renal Ischemia-Reperfusion InjuryAmerican Journal of Nephrology, 2002
- The T cell as a bridge between innate and adaptive immune systems: Implications for the kidneyKidney International, 2002
- Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemiaKidney International, 2001
- EFFECT OF BIOFLAVONOIDS QUERCETIN AND CURCUMIN ON ISCHEMIC RENAL INJURYTransplantation, 1998
- Recovery from postischemic acute renal failure in the ratKidney International, 1979